<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-chlorpromazine.xml</id>
  <title>Recalls Watch: Chlorpromazine</title>
  <link rel="self" href="https://recalls.watch/feed/substance-chlorpromazine.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2025-10-15T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/97584/</id>
    <title>The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: Major ChlorproMAZINE Hydrochloride Tablets and 4 more</title>
    <link href="https://recalls.watch/recall/fda/97584/"/>
    <updated>2025-10-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97533/</id>
    <title>Amerisource Health Services LLC: chlorproMAZINE Hydrochloride Tablets and 3 more</title>
    <link href="https://recalls.watch/recall/fda/97533/"/>
    <updated>2025-09-24T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97534/</id>
    <title>Zydus Pharmaceuticals (USA) Inc: Chlorpromazine Hydrochloride Tablets and 9 more</title>
    <link href="https://recalls.watch/recall/fda/97534/"/>
    <updated>2025-09-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97438/</id>
    <title>Amneal Pharmaceuticals, LLC: Sulfamethoxazole and Trimethoprim Tablets and 4 more</title>
    <link href="https://recalls.watch/recall/fda/97438/"/>
    <updated>2025-09-10T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96679/</id>
    <title>The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: ChlorproMAZINE Hydrochloride Tablets</title>
    <link href="https://recalls.watch/recall/fda/96679/"/>
    <updated>2025-04-23T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96626/</id>
    <title>Zydus Pharmaceuticals (USA) Inc: chlorproMAZINE Hydrochloride Tablets</title>
    <link href="https://recalls.watch/recall/fda/96626/"/>
    <updated>2025-04-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95658/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: chlorproMAZINE Hydrochloride Tablets</title>
    <link href="https://recalls.watch/recall/fda/95658/"/>
    <updated>2025-04-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95936/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: chlorproMAZINE Hydrochloride Tablets and 1 more</title>
    <link href="https://recalls.watch/recall/fda/95936/"/>
    <updated>2025-01-01T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/65360/</id>
    <title>Lowlite Investments, Inc. D/B/A Olympia Pharmacy: Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml and 104 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=65360"/>
    <updated>2013-07-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes</summary>
  </entry>
</feed>
